Former US President Donald Trump has recently intensified his engagement on both international and domestic fronts. He has articulated significant policy declarations and offered endorsements, clearly demonstrating his characteristic approach to foreign affairs and economic strategies. These actions, ranging from supporting a key Asian ally to questioning existing arms control treaties and initiating a healthcare cost reduction plan, suggest a potential shift in American policy direction should he pursue future political office.
On Thursday, Trump publicly declared his support for Sanae Takaichi, the Prime Minister of Japan, in anticipation of an upcoming snap election. This endorsement, shared through his social media platform Truth Social, followed Takaichi’s assumption of leadership in October and her subsequent call for an election. The endorsement seems to stem from a shared conviction in strengthening defence capabilities, a point Takaichi has previously emphasized in efforts to improve US-Japan relations strained by Trump's past tariff impositions. This aligns with Trump's established pattern of backing leaders who share similar ideological viewpoints, having previously supported figures like Argentina's President Javier Milei and Hungary's Prime Minister Viktor Orban.
Concurrently, Trump firmly rejected Russian President Vladimir Putin's proposal to unilaterally extend the New START Treaty, a critical agreement for nuclear arms control which recently expired. Putin had offered a one-year extension, a move intended to prevent a potential arms race. However, Trump asserted the treaty had been "badly negotiated" and expressed a preference for a new, more advantageous, and modernized agreement, potentially including China in future negotiations. This position signals a departure from established diplomatic norms and a desire for a more assertive negotiation stance.
Domestically, Trump has also launched TrumpRx, a website designed to reduce the financial burden of high prescription drug costs for American consumers. Promising significant savings and improved health, the platform allows users to find medications, access discount coupons, and present them at pharmacies. This initiative, reportedly supported by sixteen pharmaceutical companies that agreed to lower prices to avoid potential US tariffs, positions Trump as a challenger to the existing healthcare industry. The program is being presented as a direct benefit to consumers, particularly those utilizing government programs like Medicaid.
However, these political activities are unfolding amidst growing global apprehension regarding democratic decline and human rights violations. A recent report by Human Rights Watch (HRW) vividly describes a "democratic recession," citing abuses in various countries, including those that occurred during the Trump administration. Philippe Bolopion, Executive Director of HRW, cautioned that these trends are jeopardizing human rights and the international order. The report specifically details actions detrimental to rights-based systems, such as undermining electoral integrity and attacking judicial independence. HRW forecasts that the US might reach a "tipping point" concerning its commitment to fundamental rights by 2025, a prediction casting a significant shadow over Trump's potential future influence. The combination of Trump's assertive foreign policy positions and the sobering assessment of global human rights trends suggests a period of considerable geopolitical and societal transformation.